2013/653/EU: Commission Implementing Decision of 12 November 2013 as regards a Union financial aid towards a coordinated control plan for antimicrobial resistance monitoring in zoonotic agents in 2014 (notified under document C(2013) 7289)
Date: 2013-11-12
Institutions: European Commission
Subjects: EU aid, financial aid, microorganism, poultry, veterinary inspection, veterinary medicinal product, zoonosis




L_2013303EN.01004001.xml










14.11.2013   


EN


Official Journal of the European Union


L 303/40








            COMMISSION IMPLEMENTING DECISION
         
of 12 November 2013
         
as regards a Union financial aid towards a coordinated control plan for antimicrobial resistance monitoring in zoonotic agents in 2014
(notified under document C(2013) 7289)
(2013/653/EU)


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (1), and in particular Article 66 thereof,


Having regard to Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No 1605/2002 (2) (the Financial Regulation), and in particular Article 84(2) thereof,

Whereas:







(1)


Regulation (EC) No 882/2004 lays down, among others, procedures governing the financial support from the Union to conduct measures necessary to ensure the application of Regulation (EC) No 882/2004.












(2)


Directive 2003/99/EC of the European Parliament and of the Council (3) provides that Member States shall ensure that monitoring provides comparable data on the occurrence of antimicrobial resistance (AMR) in zoonotic agents and, in so far as they present a threat to public health, other agents.












(3)


Article 7(3) of this Directive provides that the Commission shall set out detailed rules for the implementation of monitoring of antimicrobial resistance.












(4)


Several scientific opinions published by the European Food Safety Authority and reports published by the World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO) and the World Animal Health Organisation (OIE) call for a harmonised monitoring of antimicrobial resistance (AMR) in zoonotic and commensal bacteria, present in animals or food. The Commission therefore laid down detailed rules for harmonised monitoring and reporting of AMR in accordance with Article 7(3) of Directive 2003/99/EC to be carried out by the Member States in Commission Implementing Decision 2013/652/EU (4).












(5)


This harmonised monitoring must be performed in accordance with Article 3 of Regulation (EC) No 882/2004 ensuring that official controls are carried out regularly, on a risk basis and with appropriate frequency, so as to achieve the objectives of that Regulation taking account of identified risks associated with animals, feed or food, feed or food businesses, the use of feed or food or any process, material, substance, activity or operation that may influence feed or food safety, animal health or animal welfare.












(6)


In order to facilitate smooth and fast application of this monitoring, the Union should financially support the Member States which carry out this monitoring at the most appropriate level as provided for in Article 66(1)(c) of Regulation (EC) No 882/2004.












(7)


In accordance with Article 84 of the Financial Regulation and Article 94 of the Commission Delegated Regulation (EU) No 1268/2012 (5), the commitment of expenditure from the Union budget shall be preceded by a financing decision setting out the essential elements of the action involving expenditure and adopted by the institution or the authorities to which powers have been delegated by the institution.












(8)


The measures eligible for Union financial support are defined within the current Implementing Decision.












(9)


The financial contribution from the Union should be granted subject to the condition that the tests and analyses have been carried out in accordance with the present Implementing Decision and with Implementing Decision 2013/652/EU and that the competent authorities supply all the necessary information within the time limits laid down in the present Implementing Decision.












(10)


For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Union should be expressed in euro and the conversion rate for expenditure in a currency other than the euro should be set,





HAS ADOPTED THIS DECISION:



Article 1

Subject matter

The Union shall contribute to the costs incurred by the Member States relating to the application of the harmonised antimicrobial resistance monitoring in accordance with Implementing Decision 2013/652/EU on samples of poultry collected between 1 January and 31 December 2014, with a total maximum amount of EUR 1 407 585 to be financed from line 17 04 07 01.


Article 2

Eligible costs

The Union financial contribution:






(a)


shall be at a rate of 50 % of the costs incurred by each Member State to implement the monitoring referred to in Article 1 of Implementing Decision 2013/652/EU and performed by the competent authority;










(b)


shall not exceed the following:






(i)


EUR 8 for staff costs per caecal sampling;










(ii)


EUR 11 per E. coli isolation and identification;










(iii)


EUR 21,5 per Campylobacter isolation and identification;










(iv)


EUR 15 per antimicrobial susceptibility testing (AST) of each Salmonella or E. coli isolate;










(v)


EUR 15 per AST of each Campylobacter isolate;










(vi)


EUR 17,5 per characterisation and classification of Salmonella or E. coli isolates showing resistance to third-generation cephalosporins and meropenem;










(vii)


EUR 22 per Salmonella serotyping;










(viii)


the maximum amounts indicated in Annex I;














(c)


only the costs indicated in Annex II shall be eligible for contribution.






Article 3

Eligibility rules


1.   The Union contribution is subject to the following conditions:






(a)


by 31 May 2015, the Member States have provided to the European Food Safety Authority who was mandated for this task by the European Commission, with a technical report covering at least the information requested in Part B of the Annex to Implementing Decision 2013/652/EU;










(b)


by 31 May 2015, the Member States have provided the Commission, in electronic form, with a financial report according to the format laid out in Annex III to this Decision. In order to be eligible for funding, the expenditure incurred must have been paid before the submission of the claim. The supporting documents evidencing all the expenditure referred to in the financial report shall be sent to the Commission on request only.






2.   The Commission may reduce the amount of the contributions referred to in Annex I in cases where the conditions referred to in paragraph 1 of this Article are not met, having regard to the nature and gravity of the non-compliance and to the potential financial loss for the Union.



Article 4

Conversion rate for expenditure

For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Union should be expressed in euro. When a Member State’s expenditure is in a currency other than euro, the Member State shall convert it into euro by applying the most recent exchange rate set by the European Central Bank prior to the first day of the month in which the application is submitted by the Member State concerned.


Article 5
This Decision constitutes a financing decision in the meaning of Article 84 of Regulation (EU, Euratom) No 966/2012.


Article 6
This Decision is addressed to the Member States.




Done at Brussels, 12 November 2013.


For the Commission

Tonio BORG
            

Member of the Commission






(1)  
            OJ L 165, 30.4.2004, p. 1.

(2)  
            OJ L 298, 26.10.2012, p. 1.

(3)  Directive 2003/99/EC of the European Parliament and of the Council of 17 November 2003 on the monitoring of zoonoses and zoonotic agents (OJ L 325, 12.12.2003, p. 31).

(4)  Commission Implementing Decision 2013/652/EU of 12 November 2013 on the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria (see page 26 of this Official Journal).

(5)  Commission Delegated Regulation (EU) No 1268/2012 of 29 October 2012 on the rules of application of Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council on the financial rules applicable to the general budget of the Union (OJ L 362, 31.12.2012, p. 1).




ANNEX I

Table 1












Member States


Number of




Caecal samples


Isolation/Identification & AST


AST Salmonella



Serotyping Salmonella



Characterisation and classification of resistant isolates





Campylobacter




E. coli





BE


850 


170 


170 


550 


550 


150 




BG


425 


85 


85 


200 


200 


50 




CZ


850 


170 


170 


550 


550 


150 




DK


850 


170 


170 


250 


250 


100 




DE


1 700 


340 


340 


700 


700 


200 




EE


425 


85 


85 


100 


100 


50 




IE


850 


170 


170 


300 


300 


100 




EL


850 


170 


170 


450 


450 


100 




ES


1 700 


340 


340 


1 000 


1 000 


250 




FR


1 700 


340 


340 


800 


800 


250 




HR


425 


85 


85 


250 


250 


100 




IT


1 700 


340 


340 


800 


800 


250 




CY


425 


85 


85 


200 


200 


100 




LV


425 


85 


85 


100 


100 


50 




LT


425 


85 


85 


200 


200 


50 




LU


425 


85 


85 


100 


100 


50 




HU


1 700 


340 


340 


900 


900 


250 




MT


425 


85 


85 


100 


100 


50 




NL


850 


170 


170 


450 


450 


150 




AT


1 700 


340 


340 


550 


550 


200 




PL


1 700 


340 


340 


800 


800 


250 




PT


1 700 


340 


340 


500 


500 


200 




RO


850 


170 


170 


600 


600 


150 




SI


425 


85 


85 


200 


200 


50 




SK


425 


85 


85 


100 


100 


50 




FI


850 


170 


170 


50 


50 


50 




SE


850 


170 


170 


50 


50 


50 




UK


1 700 


340 


340 


800 


800 


250 




Total


27 200 


5 440 


5 440 


11 650 


11 650 


3 700 








Table 2















Member States


Maximum reimbursement (EUR)




Caecal sampling



E. coli Isolation & identification



Campylobacter Isolation & identification



Salmonella serotyping


AST


Characterisation & classification resistant isolates


Total


Overheads included (7 %)





Salmonella + E. coli




Campylobacter





BE


6 800 


2 200 


14 800 


14 700 


10 800 


2 600 


2 700 


54 600 



58 422 





BG


500 


2 200 


8 600 


5 700 


4 000 


1 300 


900 


23 200 



24 824 





CZ


1 600 


1 300 


9 100 


7 200 


8 800 


1 200 


1 900 


31 100 



33 277 





DK


6 800 


2 200 


18 300 


9 300 


6 300 


2 600 


1 800 


47 300 



50 611 





DE


13 600 


4 400 


36 600 


22 900 


14 100 


4 400 


3 500 


99 500 



106 465 





EE


400 


1 000 


3 300 


4 100 


2 200 


1 100 


200 


12 300 



13 161 





IE


5 900 


1 200 


11 400 


8 700 


5 000 


1 400 


1 200 


34 800 



37 236 





EL


2 000 


2 200 


14 900 


7 700 


8 500 


2 600 


1 300 


39 200 



41 944 





ES


5 200 


1 800 


14 600 


29 500 


20 100 


5 100 


4 400 


80 700 



86 349 





FR


13 600 


4 400 


36 600 


25 100 


17 100 


4 100 


4 400 


105 300 



112 671 





HR


2 000 


2 200 


500 


6 500 


5 100 


1 300 


1 200 


18 800 



20 116 





IT


13 600 


4 400 


25 000 


16 500 


12 200 


3 700 


2 700 


78 100 



83 567 





CY


1 400 


2 200 


9 200 


6 300 


3 800 


1 000 


1 300 


25 200 



26 964 





LV


700 


900 


3 400 


3 900 


1 600 


800 


500 


11 800 



12 626 





LT


400 


2 000 


4 900 


2 900 


3 200 


600 


600 


14 600 



15 622 





LU


3 400 


2 200 


9 200 


4 100 


2 800 


1 300 


900 


23 900 



25 573 





HU


3 600 


2 500 


29 600 


25 000 


13 100 


4 000 


2 900 


80 700 



86 349 





MT


1 300 


500 


5 500 


3 500 


2 000 


700 


900 


14 400 



15 408 





NL


6 800 


1 300 


12 500 


7 100 


7 900 


2 600 


2 700 


40 900 



43 763 





AT


13 600 


4 400 


36 600 


17 000 


13 400 


5 100 


3 500 


93 600 



100 152 





PL


6 200 


2 200 


17 800 


17 700 


7 700 


3 600 


1 900 


57 100 



61 097 





PT


4 400 


3 900 


36 600 


18 500 


5 600 


2 100 


1 700 


72 800 



77 896 





RO


6 800 


1 500 


9 000 


17 000 


11 600 


2 600 


2 700 


51 200 



54 784 





SI


3 400 


1 900 


9 200 


5 200 


2 700 


1 300 


900 


24 600 



26 322 





SK


1 600 


2 000 


9 200 


3 300 


2 800 


1 300 


900 


21 100 



22 577 





FI


6 800 


1 900 


8 300 


0 


3 300 


2 300 


900 


23 500 



25 145 





SE


6 800 


1 300 


10 700 


4 900 


3 000 


2 400 


600 


29 700 



31 779 





UK


13 600 


3 600 


36 600 


25 100 


17 100 


5 100 


4 400 


105 500 



112 885 





Total


152 800 


63 800 


442 000 


319 400 


215 800 


68 200 


53 500 


1 315 500 


1 407 585 









ANNEX II

ELIGIBILITY RULES

1.   Laboratory costs







—


Staff costs shall be limited to actual attributable labour costs (wages, social charges and retirement costs) accrued in implementation of Implementing Decision 2013/652/EU. To this end timesheets have to be maintained.










—


Reimbursement of consumables shall be based on actual costs incurred by Member States to perform the tests at the laboratory designated by the competent authority.










—


Test kits, reagents and all other consumables shall only be reimbursed if used specifically in the performance of the following tests:






(i)



E. coli isolation and identification;










(ii)



Campylobacter isolation and identification;










(iii)


AST of Salmonella and E. coli isolates;










(iv)


AST of Campylobacter isolates;










(v)


Characterisation and classification of Salmonella and E. coli isolates showing resistance to third-generation cephalosporins and meropenem;










(vi)



Salmonella serotyping.








2.   Sampling costs

Costs for sampling shall be limited to staff costs of work within the slaughterhouse for the actual attributable labour (wages, social charges and retirement costs) accrued in implementation of Implementing Decision 2013/652/EU. To this end timesheets have to be maintained.
3.   Overheads

A flat rate contribution of 7 % calculated on the basis of all direct eligible costs may be claimed.
4.   The expenditure submitted by the Member States for a financial contribution by the Union shall be expressed in euro and shall exclude value added tax (VAT) and all other taxes.





ANNEX III

TEMPLATE FOR FINANCIAL REPORTS AS REFERRED TO IN ARTICLE 3(1)(B)

Reporting period: 2014
Member State: …
Reference number of Commission Implementing Decision providing a financial contribution from the Union: 2013/653/EU

Laboratory costs (total effective eligible costs)










E. coli isolation and identification





Staff category


Number of working hours


Rate (EUR per hour)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


 


 




Consumables (description)


Quantity


Unit cost (EUR)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


Total (EUR)


 




Total nr of tests:


 



Unit cost per analysis (EUR)



 





Campylobacter isolation and identification





Staff category


Number of working hours


Rate (EUR per hour)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


 


 




Consumables (description)


Quantity


Unit cost (EUR)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


Total (EUR)


 




Total nr of tests:


 



Unit cost per analysis (EUR)



 




AST Salmonella and E. coli isolates





Staff category


Number of working hours


Rate (EUR per hour)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


 


 




Consumables (description)


Quantity


Unit cost (EUR)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


Total (EUR)


 




Total nr of tests:


 



Unit cost per analysis (EUR)



 




AST Campylobacter isolates





Staff category


Number of working hours


Rate (EUR per hour)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


 


 




Consumables (description)


Quantity


Unit cost (EUR)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


Total (EUR)


 




Total nr of tests:


 



Unit cost per analysis (EUR)



 




Characterisation and classification of resistant isolates





Staff category


Number of working hours


Rate (EUR per hour)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


 


 




Consumables (description)


Quantity


Unit cost (EUR)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


Total (EUR)


 




Total nr of tests:


 



Unit cost per analysis (EUR)



 





Salmonella serotyping





Staff category


Number of working hours


Rate (EUR per hour)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


 


 




Consumables (description)


Quantity


Unit cost (EUR)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


Total (EUR)


 




Total nr of tests:


 



Unit cost per analysis (EUR)



 








Sampling costs (total effective eligible costs)









Staff category


Number of working hours


Rate (EUR per hour)


Total (EUR)




…


 


 


 




…


 


 


 




 


 


 


 




 


 


 


 




 


 


 


 




 


 


Total (EUR)


 




Total nr of samples:


 



Unit cost per sample (EUR)



 













Total expenditure for the coordinated control programme (real costs, VAT excluded) (EUR):


…




Declaration by the beneficiary
We certify that:






—


the expenditure listed above was incurred in the performance of tasks described in Implementing Decision 2013/652/EU and directly related to the implementation of the coordinated control plan for which financial support was granted according to Implementing Decision 2013/653/EU;










—


the expenditure was actually incurred, paid by the submission date of the current claim, accurately accounted for and eligible under the provisions of Implementing Decision 2013/653/EU;










—


all supporting documents supporting for the costs are available for audit purposes;










—


no other contribution from the Union was requested for this coordinated control plan.




Date: …
Person responsible: …
Signature: …